SKSung Min Kim

Sung Min Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sung Min Kim has a total of 77 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers
    Open Access

    Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non–Muscle-Invasive Bladder Cancer

    by John L. Gore, Erika M. Wolff, Michael G. Nash, Bryan A. Comstock, Scott M. Gilbert, Sam S. Chang, Stephanie Chisolm, Douglas B. MacLean, Jonathan L. Wright, Max R. Kates, et al.

    PURPOSE: To compare patient-reported and clinical outcomes between radical cystectomy (RC) and bladder-sparing therapy (BST) in patients with recurrent high-grade non–muscle-invasive bladder cancer (NMIBC). PATIENTS AND METHODS: This pragmatic, prospective observational cohort study was designed with patients, who selected and prioritized outcomes. Eligible adults were candidates for both RC or BST, had previous induction Bacillus Calmette-Guérin (BCG), and received their last treatment within 12 months. The primary outcome was the EORTC-QLQ-C30 physical function scale at 12 months. Secondary outcomes included other EORTC-QLQ-C30 scales, depression, anxiety, bladder cancer–specific quality of life (QOL), financial burden, and cancer-specific outcomes. Targeted maximum likelihood estimation (TMLE) was used to calculate average treatment effect (ATE) estimates between arms. Inverse probability weighted risk ratios (wRR) were calculated using quasi-Poisson regression. RESULTS: Of 570 participants (mean age 71.4 years; 21% female), 371 selected BST and 199 selected RC. Physical function was significantly worse in the RC arm at 3 months; by 9 months, there was no difference between arms, and at 12 months, physical function did not differ (ATE, 0.9; 95% CI, –0.6 to 2.4; P = .22). RC was associated with better emotional function, generic health-related QOL, and financial burden, and lower depression and anxiety, while BST was associated with better bowel and sexual health. Cancer-specific survival was 99% for BST versus 96% for RC (wRR, 0.99; 95% CI, 0.97 to 1.01). RC was associated with a higher risk of adverse events and serious adverse events, including a 90-day mortality rate of 2.5%. CONCLUSION: Most patient-prioritized outcomes were similar or better among participants who chose RC compared with BST. These findings support the continued role of RC in managing recurrent high-grade NMIBC.


  • Open Access

    Engaging Black Individuals and Community Members in Prostate Cancer Priority Setting Research Activities: An Application of the World Café Method

    by Yohali Burrola-Mendez, Jenney R. Lee, Dante’ Morehead, Sung Min Kim, Liz Sage, John Masembe, Erika M. Wolff, Yaw A. Nyame

    Purpose: Patient-centered and community-centered approaches are essential for understanding the perspectives and needs of historically excluded populations, such as Black communities, and for addressing research inequities. This study aimed to gather feedback on 4 patient-driven and community-driven projects, identifying barriers and facilitators to equitable care and key questions to guide future studies aimed at improving prostate cancer care for Black individuals. Methods: During a community symposium, we used the World Café method to facilitate dialogue among Black individuals with prostate cancer, community members, and our research team. The World Café included 4 discussion topics covering prostate cancer care, including carcinogenesis, screening, diagnosis, treatment, and survivorship. Participants rotated every 20 minutes to share their insights. We analyzed the data thematically, using both inductive methods to uncover new patterns and deductive coding based on a framework addressing structural and social determinants of equity. Results: The World Café had 20 participants, mostly Black men with a history of prostate cancer (75%). Barriers to participation in genetic studies, screening, and treatment included limited access to information, mistrust of healthcare providers, reluctance toward invasive procedures, and lack of social and emotional support. Concerns about sexual, psychological, and mental well-being were also cited as barriers to research and care. In addition, fears related to diagnosis and prognosis contributed to avoidance of research or care. Conclusions: The World Café effectively engaged Black prostate cancer patients and caregivers, offering insights into factors contributing to exclusion from research and treatment. We recommend this approach for future community-partnered research.